The Latest Clinical Articles in Gastroenterology & GastroIntestinal

1Effect of immunosuppressive therapies for the treatment of inflammatory bowel disease on response to routine vaccinations: a meta-analysisDigestive Diseases and Sciences, March 31, 2015  Clinical Article
2Improved pharmacodynamics and pharmacokinetics after I.V. application of peginterferon alfa-2a in hepatitis C null-respondersLiver International, March 31, 2015  Clinical Article
3Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009Neurogastroenterology & Motility, March 31, 2015  Clinical Article
4Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysisDiseases of the Esophagus, March 31, 2015  Evidence Based Medicine
5Tenofovir disoproxil fumarate has a substantial efficacy against multidrug resistant strains of hepatitis B virusLiver International, March 31, 2015  Clinical Article
6Helicobacter pylori negative gastric cancer: characteristics and endoscopic findingsDigestive Endoscopy, March 31, 2015  Review Article
7Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosisClinical Gastroenterology and Hepatology , March 31, 2015  Clinical Article
8Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitisDigestion, March 31, 2015  Clinical Article
9Status of competency-based medical education in endoscopy training: A nationwide survey of US ACGME-Accredited Gastroenterology Training ProgramsThe American Journal of Gastroenterology, March 31, 2015  Clinical Article
10Breath methane excretion is not an accurate marker of colonic methane production in irritable bowel syndromeThe American Journal of Gastroenterology, March 31, 2015  Clinical Article
1Genetic background determines whether aspirin/NSAIDS will reduce colorectal cancer riskMassachusetts General Hospital, March 31, 2015
2Drinking raw milk dramatically increases risk for foodborne illness, analysis findsJohns Hopkins Bloomberg School of Public Health, March 31, 2015
3ASCP, CAP, AMP, and ASCO issue draft colorectal cancer molecular marker testing guideline and announce opening of public comment periodAmerican Society of Clinical Oncology (ASCO) News, March 31, 2015
4FDA warns against combination of hepatitis C treatment and antiarrhythmic drugAmerican College of Cardiology News, March 31, 2015
5MAIT cell alterations involved in obesity and T2 diabetesCentre National de la Recherche Scientifique News, March 31, 2015
6Researchers reverse type 2 diabetes and fatty liver diseaseUniversity of Copenhagen Faculty of Health and Medical Sciences News, March 30, 2015
7How our DNA may prevent bowel cancerUniversity of Melbourne News, March 30, 2015
8American College of Physicians joins HHS in accelerating alternative payment methods through ‘Health Care Payment Learning and Action Network’ American College of Physicians News, March 26, 2015
9Exciting data presented at the 4th Gut Microbiota For Health SummitAmerican Gastroenterological Association News, March 23, 2015
10NCCS pioneers new drug regimen which reduces toxicities for renal cancer patientsNational Cancer Centre Singapore News, March 23, 2015

Show Me:

Risk factors for intra-abdominal abscesses in Crohn’s disease

As reported in Digestion, uncontrolled CRP at week 14 of therapy with infliximab (OR=1.36) and early loss of response to infliximab (OR=5.36) are independent risk factors for intra-abdominal abscesses in patients with Crohn’s disease.

Decreased PTPN12 expression associated with poor prognosis in HCC

As reported in PLoS ONE, the expression of PTPN12 was decreased in hepatocellular carcinoma tissue samples compared with adjacent normal tissues. Furthermore, decreased PTPN12 expression was associated with tumor recurrence, decreased cancer-specific survival, and decreased recurrence-free survival.

Risk factors for CHC-related death identified

As reported in the World Journal of Gastroenterology, the following risk factors for chronic hepatitis C (CHC)-related deaths have been identified (n=8250 CHC patients; n=144 CHC-related deaths): α-IFN therapy (AOR=0.53); liver cirrhosis (AOR=2.89); hepatocellular carcinoma versus CHC (AOR=8.82); hypertension (AOR=1.76); alcohol consumption (AOR=1.73); and HBsAg positivity (AOR=22.28).

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocEndoscopic therapy should be standard of care for mucosal adenocarcinoma of the esophagus.

Clinical Pearl from Smartest DocOlder age and non-Caucasian race are risk factors for recurrence of Barrett's esophagus.

Clinical Pearl from Smartest DocAbsorbatox is a non-absorbable aluminosilicate with potential gastroprotective benefits.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here